Ironwood repays $200M convertible notes at maturity using cash and revolver; CFO adds COO role

IRONWOOD PHARMACEUTICALS INC

Repaid $200M 0.75% Convertible Senior Notes due 2024 on June 17 using $50M cash and $150M from $500M revolver.
Outstanding balance on $500M revolver increased to $425M following the $150M draw.
Expects ~$100M cash and cash equivalents as of June 30, 2024 (preliminary estimate).
Sravan K. Emany, current CFO, also appointed Chief Operating Officer effective immediately.
Emany has been CFO since Dec 2021; no family relationships or transactions disclosed.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Sravan K. Emany

Senior Vice President, Chief Operating Officer and Chief Financial Officer

IRWD · IRONWOOD PHARMACEUTICALS INC

Effective: 2024-06-18
Filed: June 20, 2024, 7:59 PM ET

On June 18, 2024, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) appointed Sravan K. Emany, age 46, the Company’s Senior Vice President, Chief Financial Officer, to the position of Senior Vice President, Chief Operating Officer and Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sravan K. Emany was appointed as Senior Vice President, Chief Operating Officer and Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC.

Action: appointed
Role: Senior Vice President, Chief Operating Officer and Chief Financial Officer

Exact text from the filing

On June 18, 2024, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) appointed Sravan K. Emany, age 46, the Company’s Senior Vice President, Chief Financial Officer, to the position of Senior Vice President, Chief Operating Officer and Chief Financial Officer, effective immediately.

View on SEC.gov

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-24-073391

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.